<- Go Home
Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Market Cap
$5.4B
Volume
1.7M
Cash and Equivalents
$171.4M
EBITDA
$396.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.0B
Profit Margin
20.01%
52 Week High
$35.53
52 Week Low
$21.39
Dividend
N/A
Price / Book Value
3.97
Price / Earnings
26.15
Price / Tangible Book Value
-9.05
Enterprise Value
$6.4B
Enterprise Value / EBITDA
14.69
Operating Income
$332.0M
Return on Equity
15.38%
Return on Assets
6.33
Cash and Short Term Investments
$178.9M
Debt
$1.2B
Equity
$1.4B
Revenue
$5.2B
Unlevered FCF
$320.5M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium